Cite
MLA Citation
Heinz Wiendl et al.. “116 Serum immunoglobulin levels and infection risk in Phase 3 ofatumumab trials in relapsing multiple sclerosis.” Journal of neurology, neurosurgery and psychiatry, vol. 93, no. 6, 2022, p. A137. http://access.bl.uk/ark:/81055/vdc_100158620559.0x000050